Hiroaki Saito1, Yoshinori Yamada2, Seigo Takaya2, Tomohiro Osaki2, Masahide Ikeguchi2. 1. Department of Surgery, Division of Surgical Oncology, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan. sai10@med.tottori-u.ac.jp. 2. Department of Surgery, Division of Surgical Oncology, Tottori University School of Medicine, 36-1 Nishi-cho, Yonago, 683-8504, Japan.
Abstract
PURPOSE: There is accumulating evidence that inflammation is linked to cancer development and progression. Interleukin-17 (IL-17), an inflammatory cytokine, is produced by CD 8+ T cells (Tc17 cells); however, the specific role of Tc17 cells in tumor immunity against gastric cancer remains unclear. METHODS: The prevalence of Tc17 cells in both peripheral blood mononuclear cells and gastric tissue was evaluated by multicolor flow cytometry and the concentration of IL-17 in sera was quantitated by an enzyme-linked immunosorbent assay. RESULTS: Circulating Tc17 cells were significantly more numerous in gastric cancer patients than in controls, and significantly more numerous before surgery than after surgery. IL-17 concentrations in gastric cancer patients and healthy controls were 0.51 ± 0.54 and 0.084 ± 0.084 pg/mL, respectively, with this difference being significant. The percentage of Tc17 cells was significantly related to serum IL-17 concentration. Tc17 cells were significantly more numerous than peripheral blood mononuclear cells in gastric cancer tissue. Furthermore, Tc17 cells were more numerous in cancerous gastric tissue than in normal gastric tissue. CONCLUSIONS: Tc17 cells may be the main source of IL-17 in gastric cancer patients and thus involved in the progression of gastric cancer.
PURPOSE: There is accumulating evidence that inflammation is linked to cancer development and progression. Interleukin-17 (IL-17), an inflammatory cytokine, is produced by CD 8+ T cells (Tc17 cells); however, the specific role of Tc17 cells in tumor immunity against gastric cancer remains unclear. METHODS: The prevalence of Tc17 cells in both peripheral blood mononuclear cells and gastric tissue was evaluated by multicolor flow cytometry and the concentration of IL-17 in sera was quantitated by an enzyme-linked immunosorbent assay. RESULTS: Circulating Tc17 cells were significantly more numerous in gastric cancerpatients than in controls, and significantly more numerous before surgery than after surgery. IL-17 concentrations in gastric cancerpatients and healthy controls were 0.51 ± 0.54 and 0.084 ± 0.084 pg/mL, respectively, with this difference being significant. The percentage of Tc17 cells was significantly related to serum IL-17 concentration. Tc17 cells were significantly more numerous than peripheral blood mononuclear cells in gastric cancer tissue. Furthermore, Tc17 cells were more numerous in cancerous gastric tissue than in normal gastric tissue. CONCLUSIONS: Tc17 cells may be the main source of IL-17 in gastric cancerpatients and thus involved in the progression of gastric cancer.
Entities:
Keywords:
CD 8+ T cells; Gastric cancer; Interleukin-17
Authors: E Solcia; R Fiocca; O Luinetti; L Villani; L Padovan; D Calistri; G N Ranzani; A Chiaravalli; C Capella Journal: Am J Surg Pathol Date: 1996 Impact factor: 6.394
Authors: D V Jovanovic; J A Di Battista; J Martel-Pelletier; F C Jolicoeur; Y He; M Zhang; F Mineau; J P Pelletier Journal: J Immunol Date: 1998-04-01 Impact factor: 5.422
Authors: F Fossiez; O Djossou; P Chomarat; L Flores-Romo; S Ait-Yahia; C Maat; J J Pin; P Garrone; E Garcia; S Saeland; D Blanchard; C Gaillard; B Das Mahapatra; E Rouvier; P Golstein; J Banchereau; S Lebecque Journal: J Exp Med Date: 1996-06-01 Impact factor: 14.307
Authors: Silvia Zappavigna; Alessia Maria Cossu; Anna Grimaldi; Marco Bocchetti; Giuseppe Andrea Ferraro; Giovanni Francesco Nicoletti; Rosanna Filosa; Michele Caraglia Journal: Int J Mol Sci Date: 2020-04-09 Impact factor: 5.923